The U.S. Supreme Court ruled Monday it will not take up an appeal from a group of drug makers attempting to block negotiations for lower drug prices.

The Supreme Court has rejected appeals from pharmaceutical companies that object to negotiating Medicare drug prices with the federal government.

Pharmaceutical companies are trying to prevent Medicare from negotiating discounts for drugs. Their legal challenges have been unsuccessful.

The US Supreme Court on Monday rejected a series of appeals from several of the nation’s largest drugmakers challenging a program that is expected to save taxpayers and the…

The rejection may make the pharma firms remaining lawsuits more difficult.

The negotiation program was created as part of the 2022 Inflation Reduction Act, which capped years of debate over whether the federal government should be allowed to haggle…

The U.S. Supreme Court ruled Monday it will not take up an appeal from a group of drug makers attempting to block negotiations for lower drug prices.